Jamieson 10 billion
Limosilactobacillus reuteri UALre-16
Strain code: UALre-16
CFU: 10 billion CFU
View product →Probiotics show potential benefits for skin health, particularly in wound healing and improving reactive skin conditions, with evidence strongest for certain strains like Limosilactobacillus reuteri and Bifidobacterium longum.
High-quality systematic reviews and randomized controlled trials indicate that probiotics can positively influence wound healing by reducing infection rates, enhancing re-epithelization, and modulating immune responses. Limosilactobacillus reuteri has demonstrated improved healing outcomes after oral and surgical wounds, while Bifidobacterium longum lysate has shown benefits in reducing skin sensitivity and improving skin barrier function in reactive skin. Topical application of probiotics also shows promise in accelerating wound closure in animal models. However, some studies report mixed or non-significant results, and the effectiveness may depend on the probiotic strain, wound type, and application method. Safety profiles are generally favorable with no serious adverse effects reported.
Evidence supports oral administration for surgical and oral wound healing; effects on pain are less clear.
Topical application beneficial for sensitive/reactive skin; effects likely related to immune modulation.
Promising for topical use but human data are limited.
Experimental approach with potential but limited clinical data.
No serious adverse effects were reported across studies. Probiotics were generally well tolerated in oral and topical applications. Minor side effects were rare or absent.
Evidence varies in quality and is sometimes limited by small sample sizes or pilot study designs. Strain-specific effects are important, and not all probiotics show benefits. More large-scale, well-controlled human trials are needed to confirm efficacy and optimal strains/dosages. Animal studies provide preliminary data but may not fully translate to humans.
These products contain microorganisms identified in the research analysis above.
Limosilactobacillus reuteri UALre-16
Strain code: UALre-16
CFU: 10 billion CFU
View product →
Limosilactobacillus reuteri
CFU: 60 billion CFU
View product →
Limosilactobacillus reuteri
CFU: 50 Billion CFU
View product →
Limosilactobacillus reuteri
CFU: 60 Billion CFU
View product →
Bifidobacterium longum BB536
Strain code: BB536
Bifidobacterium longum Bl-05
Strain code: Bl-05
CFU: 25 Billion CFU
View product →Probiotics.info is an educational and research platform. Its content does not constitute medical advice.
By continuing, you acknowledge our policies and agree to our Terms of Use.
Necessary cookies keep the website working. You can also allow optional cookies for analytics and referral tracking.
You can change your cookie preferences later.